PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: A potential B-cell antigen used for serological diagnosis to distinguish vaccinated controls from tuberculosis patients

Clinical Microbiology and Infection

Volumn 13, Issue 2, 2007, Pages 139-145

  Zhang, H ^a   Wang, J ^a   Lei, J ^a   Zhang, M ^a   Yang, Y ^a   Chen, Y ^b   Wang, H ^a  

^a FUDAN UNIVERSITY   (China)

^b No 6 Hospital of Zhengzhou   (China)

Author keywords

Antigen; Diagnosis; Mycobacterium tuberculosis; PPE family protein; Region of difference; Rv3425 protein

Indexed keywords

B LYMPHOCYTE ANTIGEN; BACTERIAL DNA; BACTERIAL PROTEIN; BCG VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; HISTIDINE; IMMUNOGLOBULIN G ANTIBODY; MESSENGER RNA; PROTEIN PPE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MOLECULAR CLONING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; TUBERCULOSIS; VACCINATION;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 33846283740     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01561.x     Document Type: Article

References (43)

1. World Health Organization. WHO report on global tuberculosis control. Geneva: WHO, 2003.
2. Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002; 185: 1197-1202.
3. Siddiqi N, Shamim M, Hussain S et al. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 2002; 46: 443-450.
4. Ahmed N, Caviedes L, Alam M et al. Distinctiveness of Mycobacterium tuberculosis genotypes from human immunodeficiency virus type 1-seropositive and -seronegative patients in Lima, Peru. J Clin Microbiol 2003; 41: 1712-1716.
5. Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: The current evidence. Lancet Infect Dis 2003; 3: 288-296.
6. Brock I, Munk ME, Kok-Jensen A, Andersen P. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001; 5: 462-467.
7. Ewer K, Deeks J, Alvarez L et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-1173.
8. Lalvani A, Nagvenkar P, Udwadia Z et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001; 183: 469-477.
9. Andersen AB, Hansen EB. Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein of Mycobacterium tuberculosis. Infect Immun 1989; 57: 2481-2488.
10. Lyashchenko K, Colangeli R, Houde M, Al-Jahdali H, Menzies D, Gennaro ML. Heterogeneous antibody responses in tuberculosis. Infect Immun 1998; 66: 3936-3940.
11. Silva VM, Kanaujia G, Gennaro ML, Menzies D. Factors associated with humoral response to ESAT-6, 38 kDa and 14 kDa in patients with a spectrum of tuberculosis. Int J Tuberc Lung Dis 2003; 7: 478-484.
12. Hendrickson RC, Douglass JF, Reynolds LD et al. Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis. J Clin Microbiol 2000; 38: 2354-2361.
13. Lodes MJ, Dillon DC, Mohamath R et al. Serological expression cloning and immunological evaluation of MTB48, a novel Mycobacterium tuberculosis antigen. J Clin Microbiol 2001; 39: 2485-2493.
14. Mukherjee S, Daifalla N, Zhang Y et al. Potential serological use of a recombinant protein that is a replica of a Mycobacterium tuberculosis protein found in the urine of infected mice. Clin Diagn Lab Immunol 2004; 11: 280-286.
15. Houghton RL, Lodes MJ, Dillon DC et al. Use of multiepitope polyproteins in serodiagnosis of active tuberculosis. Clin Diagn Lab Immunol 2002; 9: 883-891.
16. Banerjee S, Nandyala A, Podili R, Katoch VM, Murthy KJR, Hasnain SE. Mycobacterium tuberculosis (Mtb) isocitrate dehydrogenases show strong B cell response and distinguish vaccinated controls from TB patients. Proc Natl Acad Sci USA 2004; 101: 12652-12657.
17. Colangeli R, Heijbel A, Williams AM et al. Three-step purification of lipopolysaccharide-free, polyhistidine-tagged recombinant antigens of Mycobacterium tuberculosis. J Chromatogr B Biomed Sci Appl 1998; 714: 223-235.
18. Bahk YY, Kim SA, Kim JS et al. Antigens secreted from Mycobacterium tuberculosis: Identification by proteomics approach and test for diagnostic marker. Proteomics 2004; 4: 3299-3307.
19. Dillon DC, Alderson MR, Day CH et al. Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. J Clin Microbiol 2000; 38: 3285-3290.
20. Cole ST, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393: 537-544.
21. Cole ST. Comparative and functional genomics of the Mycobacterium tuberculosis complex. Microbiology 2002; 148: 2919-2928.
22. Ramakrishnan L, Federspiel NA, Falkow S. Granulomaspecific expression of Mycobacterium tuberculosis virulence proteins from the glycine-rich PE-PGRS family. Science 2000; 288: 1436-1439.
23. Banu S, Honore N, Saint-Joanis B, Philpott D, Prevost MC, Cole ST. Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens? Mol Microbiol 2002; 44: 9-19.
24. Brennan MJ, Delogu G, Chen Y et al. Evidence that mycobacterial PE-PGRS proteins are cell surface constituents that influence interactions with other cells. Infect Immun 2001; 69: 7326-7333.
25. Delogu G, Brennan MJ. Comparative immune response to PE and PE-PGRS antigens of Mycobacterium tuberculosis. Infect Immun 2001; 69: 5606-5611.
26. Espitia C, Laclette JP, Mondragon-Palomino M et al. The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: A new family of fibronectin-binding proteins? Microbiology 1999; 145: 3487-3495.
27. Singh KK, Zhang X, Patibandla AS, Chien P, Laal S. Antigens of Mycobacterium tuberculosis expressed during preclinical tuberculosis: serological immunodominance of proteins with repetitive amino acid sequences. Infect Immun 2001; 69: 4185-4191.
28. Choudhary RK, Mukhopadhyay S, Chakhaiyar P et al. PPE antigen Rv2430c of Mycobacterium tuberculosis induces a strong B-cell response. Infect Immun 2003; 71: 6338-6343.
29. Chakhaiyar P, Nagalakshmi Y, Aruna B, Murthy KJR, Katoch VM, Hasnain SE. Regions of high antigenicity within the hypothetical PPE major polymorphic tandem repeat open reading frame, Rv2608, show a differential humoral response and a low T cell response in various categories of patients with tuberculosis. J Infect Dis 2004; 190: 1237-1244.
30. Le Moigne V, Robreau G, Borot C, Guesdon JL, Mahana W. Expression, immunochemical characterization and localization of the Mycobacterium tuberculosis protein p27. Tuberculosis 2005; 85: 213-219.
31. Behr MA, Wilson MA, Gill WP et al. Comparative genomics of BCG vaccines by whole genome DNA microarray. Science 1999; 284: 1520-1523.
32. Chan ED, Heifets L, Iseman MD. Immunologic diagnosis of tuberculosis: A review. Tuberc Lung Dis 2000; 80: 131-140.
33. Gupta S, Bhatia R, Datta KK. Serodiagnosis of tuberculosis. J Commun Dis 1995; 27: 208-214.
34. Brusasca PN, Colangeli R, Lyashchenko KP et al. Immunological characterization of antigens encoded by the RD1 region of the Mycobacterium tuberculosis genome. Scand J Immunol 2001; 54: 448-452.
35. Chiang IH, Suo J, Bai KJ et al. Serodiagnosis of tuberculosis. A study comparing three specific mycobacterial antigens. Am J Respir Crit Care Med 1997; 156: 906-911.
36. Gupta S, Kumari S, Banwalikar JN, Gupta SK. Diagnostic utility of the estimation of mycobacterial antigen A60 specific immunoglobulins IgM, IgA and IgG in the sera of cases of adult human tuberculosis. Tuberc Lung Dis 1995; 76: 418-424.
37. Moran AJ, Treit JD, Whitney JL et al. Assessment of the serodiagnostic potential of nine novel proteins from Mycobacterium tuberculosis. FEMS Microbiol Lett 2001; 198: 31-36.
38. Raja A, Ranganathan UD, Bethunaickan R, Dharmalingam V. Serologic response to a secreted and a cytosolic antigen of Mycobacterium tuberculosis in childhood tuberculosis. Pediatr Infect Dis J 2001; 20: 1161-1164.
39. Chaudhary VK, Kulshreshta S, Gupta G et al. Expression and purification of recombinant 38-kDa and Mtb81 antigens of Mycobacterium tuberculosis for application in serodiagnosis. Protein Exp Purif 2005; 40: 169-176.
40. Kulshrestha A, Gupta A, Verma N, Sharma SK, Tyagi AK, Chaudhary VK. Expression and purification of recombinant antigens of Mycobacterium tuberculosis for application in serodiagnosis. Protein Exp Purif 2005; 44: 75-85.
41. Weldingh K, Rosenkrands I, Okkels LM, Doherty MT, Andersen P. Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosis proteins and identification of four novel serological antigens. J Clin Microbiol 2005; 43: 57-65.
42. Munk ME, Arend SM, Brock I, Ottenhoff THM, Andersen P. Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. J Infect Dis 2001; 183: 175-176.
43. Walsh A, McNerney R. Guidelines for establishing trials of new tests to diagnose tuberculosis in endemic countries. Int J Tuberc Lung Dis 2004; 8: 609-613.